RRAD and neoplasm: In contrast, mice in the P1+pre-Rad, and P1+conc-Rad groups were experienced significant tumor growth delay by 74.9% (p = 0.0021) and 64.7% (p = 0.0057) 18 days after the initial treatment, respectively, compared with P1 only group (Fig 4F).